Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: The brighter side of a sell off

In Alec Baldwin’s famous monologue from “Coffee’s For Closers”, he says – “The good news is, you’re fired. The bad news is all you’ve got is just one week to regain your jobs.&CloseCurlyDoubl...
Jonathon Brown | September 15, 2022 |

Coverage Initiated on 'Almost Famous' Energy Firm with Thermal Oil, Natural Gas Assets

Coverage Initiated on 'Almost Famous' Energy Firm with Thermal Oil, Natural Gas Assets Source: Streetwise Reports 04/18/2019 The reasons why this stock is attractive now are presented in a CIBC report. In an April 16 research note, analyst Trevor Bollan...
Streetwise Reports | April 23, 2019 |

'Undervalued' Biopharma Features Robust Pipeline, Future Upside

The case for investing in this company was made in an H.C. Wainwright & Co. report. In an April 22, 2019 research note, analyst Ram Selvaraju reported that H.C. Wainwright & Co. initiated coverage on Aquestive Therapeutics Inc. (AQST:NASDAQ) , "an undervalued spec...
Streetwise Reports | April 29, 2019 |

XPhyto: Outperforming Leading Cannabis Stocks

I recently wrote about an increasingly popular but still mostly overlooked medical cannabis company that is innovating industry-leading transdermal and oral thin film drug delivery systems. ( https://stockhouse.com/opinion/independent-reports/2020/01/08/the-golden-bullet-for-d...
Marc Davis | January 29, 2020 |

How China will drive silver to $250

Once upon a time, the Chinese government forbade ownership of all precious metals. But now, the ban has been lifted. In fact, China just introduced silver bars for investment. And now, state-run China Central Television (CCTV) is running a campaign encouraging the populati...
Peter Krauth | October 28, 2012 |

Is Scottie Resources a Deeply Undervalued Gold Junior in the World-Famous Golden Triangle?

In May I conducted an in-depth interview with Brad Rourke, president and CEO of Scottie Resources Corp. (SCOT:TSX.V) . Scottie owns/controls 18,544 hectares (~45,823 acres) in the world-famous Golden Triangle (GT) in northwestern British Columbia in Canada. Some of t...
Streetwise Reports | August 22, 2019 |

Emerging Leader in AR Positioned in the $120 Billion AR Megatrend

Starwood Research takes a look at the investment proposition offered by this tech company, asserting it is the only "pure play" stock targeting four multibillion-dollar market opportunities. NexTech AR Solutions Corp. (NTAR:CSE; NEXCF:OTCQB) is an emerging leader in ...
Streetwise Reports | November 18, 2019 |

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis | January 8, 2020 |

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Revive Therapeutics is focused on infectious diseases as well as treatments using psilocybin-based formulations. Revive Therapeutics Ltd. (RVV:TSX.V; RVVTF:OTCMKTS) , a company that focuses on repurposing drugs for infectious diseases and rare disorders, is prepari...
Streetwise Reports | June 4, 2020 |

These Technology Stocks Could Thrive in the New COVID-19 Work-from-Home Economy

Just last month, North American financial markets were chugging along, setting multiple all-time highs in February. A lot has changed in the past 30 days due to the rapid rise and global spread of the novel coronavirus (COVID-19) . The way of life we once knew has change...
Streetwise Reports | March 27, 2020 |
1 2 3 4 5 6 7 8 9 10 ...